Cargando…

Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma

AT-rich interactive domain 1A (ARID1A) is one of the most frequently mutated genes in hepatocellular carcinoma (HCC), but its clinical significance is not clarified. We aimed to evaluate the clinical significance of low ARID1A expression in HCC. By analyzing the gene expression data of liver from Ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yim, Sun Young, Kang, Sang Hee, Shin, Ji-Hyun, Jeong, Yun Seong, Sohn, Bo Hwa, Um, Soon Ho, Lee, Ju-Seog
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564185/ https://www.ncbi.nlm.nih.gov/pubmed/32878261 http://dx.doi.org/10.3390/cells9092002

Ejemplares similares

Glutamine synthetase mediates sorafenib sensitivity in β-catenin-active hepatocellular carcinoma cells
por: Sohn, Bo Hwa, et al.
Publicado: (2018)

Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma
por: He, Fei, et al.
Publicado: (2015)

Two distinct stem cell‐like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials
por: Lee, Sung Hwan, et al.
Publicado: (2022)

Long non‐coding RNAs are significantly associated with prognosis and response to therapies in gastric cancer
por: Shin, Min‐Kyue, et al.
Publicado: (2021)

Loss of Tumor Suppressor ARID1A Protein Expression Correlates with Poor Prognosis in Patients with Primary Breast Cancer
por: Cho, Hyun Deuk, et al.
Publicado: (2015)

The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis
por: Ha, Sang Yun, et al.
Publicado: (2016)

Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer
por: Wang, Dan-dan, et al.
Publicado: (2012)

P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients
por: Maynard, Janielle P., et al.
Publicado: (2015)

PRDX4 overexpression is associated with poor prognosis in gastric cancer
por: Park, Sun Yi, et al.
Publicado: (2020)

Clinical Significance of Glycolytic Metabolic Activity in Hepatocellular Carcinoma
por: Jung, Joann, et al.
Publicado: (2022)

High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Lee, Boin, et al.
Publicado: (2014)

Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma
por: Baldi, Salem, et al.
Publicado: (2021)

Downregulation of ARID1A is correlated with poor prognosis in non-small cell lung cancer
por: Wang, Tao, et al.
Publicado: (2020)

Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma
por: Sun, Ji, et al.
Publicado: (2022)

The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients
por: Ha, Sang Yun, et al.
Publicado: (2015)

Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma
por: Yang, Jee Eun, et al.
Publicado: (2014)

An Overview of the Genomic Characterization of Hepatocellular Carcinoma
por: Yim, Sun Young, et al.
Publicado: (2021)

Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma
por: Ju, Mi Ha, et al.
Publicado: (2023)

Clinically conserved genomic subtypes of gastric adenocarcinoma
por: Jeong, Yun Seong, et al.
Publicado: (2023)

Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas
por: Shin, Jin Ho, et al.
Publicado: (2015)

microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression
por: Heo, Mi Jeong, et al.
Publicado: (2014)

Long-Term Prediction Model for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Antiviral Therapy: Based on Data from Korean Patients
por: Lee, Ji Hun, et al.
Publicado: (2022)

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013)

Heat Shock Factor 1 Predicts Poor Prognosis of Gastric Cancer
por: Kim, Seok-Jun, et al.
Publicado: (2018)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors
por: Balbás-Martínez, Cristina, et al.
Publicado: (2013)

Silence of Hippo Pathway Associates with Pro-Tumoral Immunosuppression: Potential Therapeutic Target of Glioblastomas
por: Kim, Eui Hyun, et al.
Publicado: (2020)

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
por: Zhu, Zebin, et al.
Publicado: (2018)

ARID2 Chromatin Remodeler in Hepatocellular Carcinoma
por: Loesch, Robin, et al.
Publicado: (2020)

Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jung, Hae Il, et al.
Publicado: (2017)

Clinical significance of APOB inactivation in hepatocellular carcinoma
por: Lee, Gena, et al.
Publicado: (2018)

Low skull bone density is associated with poor motor prognosis in women with Parkinson’s disease
por: Jeong, Seong Ho, et al.
Publicado: (2022)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma
por: Wang, Ya-Bin, et al.
Publicado: (2019)

SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis
por: Park, Hyunjin, et al.
Publicado: (2015)

Correction: ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors
por: Balbás-Martínez, Cristina, et al.
Publicado: (2014)

Spinal cord injury after conducting transcatheter arterial chemoembolization for costal metastasis of hepatocellular carcinoma
por: Park, Sang Jung, et al.
Publicado: (2012)

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

Low Expression of Bax Predicts Poor Prognosis in Resected Non-small Cell Lung Cancer Patients with Non-squamous Histology†
por: Jeong, Seong Hyun, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_290l2473h0nuqvoqc70r3f9o1r